Absence of constitutive EGF receptor activation in ovarian cancer cell lines
1996

EGF Receptor Activation in Ovarian Cancer Cell Lines

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): C Ottensmeier, L Swanson, T Strobel, B Druker, J Niloff, SA Cannistra

Primary Institution: Dana-Farber Cancer Institute

Hypothesis

Is autocrine stimulation responsible for the proliferative response in ovarian cancer cell lines?

Conclusion

The study found no evidence of constitutive EGF receptor activation in ovarian cancer cell lines, suggesting that other pathways may drive their growth.

Supporting Evidence

  • Eight ovarian cancer cell lines were tested for EGF receptor activation.
  • None of the cell lines showed constitutive EGF receptor activation.
  • Conditioned media from ovarian cancer cell lines did not stimulate EGF receptor phosphorylation.
  • Malignant ascites from 12 patients did not induce EGF receptor activation.
  • Proliferation was not significantly inhibited by anti-EGF receptor antibody.

Takeaway

The study looked at ovarian cancer cells to see if they grow because of a special signal called EGF. They found that this signal doesn't always help the cells grow.

Methodology

The study used immunoblotting with anti-phosphotyrosine antibodies to assess EGF receptor activation in ovarian cancer cell lines.

Limitations

The study did not explore all possible mechanisms of ovarian cancer cell growth beyond EGF receptor activation.

Participant Demographics

Ovarian cancer cell lines and malignant ascites from 12 patients were used.

Statistical Information

P-Value

0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication